Top Story

FDA approves Fragmin, first anticoagulant for children

May 16, 2019
In the Journals

Higher radiation dose safely reduces graft failure after haploidentical bone marrow transplantation

May 11, 2019
Increasing the dose of total body irradiation to 400 cGy from 200 cGy greatly reduced graft failure among patients with sickle cell disease or beta-thalassemia who…
In the Journals

‘Tremendous racial and ethnic disparity’ observed in access to matched donor stem cells

May 10, 2019
Patients with cancer who need a bone marrow transplant are less likely to find a suitable match if they are of southern-European or non-European descent, according to…

Will heparin eventually be phased out with expanded use of DOACs for VTE?

HemOnc Today, May 10, 2019
POINT Unfractionated heparin has been in use as an anticoagulant for nearly a century and LMWH for more than 3 decades. Over the last decade, we have seen an explosion in…
More Headlines »

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

This activity is supported by an educational grant from Pharmacyclics LLC.

Therapeutic options continue to expand for patients with hematologic malignancies. The clinical evaluation of novel…
More »

VIDEO: Array of FDA myeloma drug approvals, new research steer field in filling ‘unmet medical need’

June 2, 2016
More »
Resource Centers

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »